EFFECT OF HARITAKI CHURNA ON CARDIOPROTECTIVE ACTION OF ARJUNA IN ISOPROTERENOL INDUCED MYOCARDIAL INFARCTION IN RATS
Journal: Indian Drugs (Vol.53, No. 1)Publication Date: 2017-01-28
Authors : Dhande S. R.; Bhutkar S. P.; Mahadik J. V.;
Page : 41-48
Keywords : ;
Abstract
Co-administration of prescribed drug with that of over the counter products may either lead to altered therapeutic effect, adverse effects or depleted efficacy of one or both drugs. One such example is geriatric patients being treated with ayurvedic cardioprotectives formulations for ischemia generally suffer from bowel movement discomfort and tend to consume herbal laxatives simultaneously without physician's consent. The proposed study was undertaken to determine whether any interaction exists when Arjuna, a cardioprotective agent is concomitantly administered orally with Haritaki churna, a laxative agent, in isoproterenol (subcutaneous administration) induced ischemic rats on pharmacodynamic level. Data was statistically evaluated by comparing the effect of combination group with that of isoproterenol control and Arjuna group on electrocardiogram (ECG) patterns, blood serum parameters, gastric motility using ONE WAY ANNOVA, p
Other Latest Articles
- DEVELOPMENT AND VALIDATION OF HIGH PERFORMANCE LIQUID CHROMATOGRAPHY METHOD FOR SIMULTANEOUS ESTIMATION OF DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULPHATE IN PHARMACEUTICAL DOSAGE FORM
- RAPID RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF LURASIDONE HYHROCHLORIDE IN BULK AND TABLET FORM
- Organizational-methodical provisions for the audit of operations with electronic money
- FORMULATION, CHARACTERIZATION AND IN VITRO EVALUTION OF GABAPENTIN FLOATING MICROSPHERES
- ISOLATION OF ALKALOID FROM ABIES WEBBIANA LEAVES AND ITS ACTIVITY
Last modified: 2017-07-20 19:47:11